Company lists · Data refreshed September 2026
Top 25 Biopharmaceutical cell therapy companies based in Japan
RevenueBase identified 70 biopharmaceutical cell therapy companies headquartered in Japan as of September 2026 and tracks 1,221 professional contacts across them, including 141 with verified work emails. Tokyo is the largest hub.
This list covers biopharmaceutical cell therapy companies headquartered in Japan, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 16, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest biopharmaceutical cell therapy companies based in Japan
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 53 contacts → | ||||
Partial evidence “REPROCELL supports nearly the entire workflow of stem cell research and pre-clinical drug development.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 2 | 23 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 3 | 22 contacts → | ||||
Strong evidence “Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 4 | 21 contacts → | ||||
Partial evidence “This company is a spinout from Takeda Pharmaceuticals and Kyoto University, focusing on the development of induced pluripotent stem cell (iPSC) technology-based regenerative…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 5 | 16 contacts → | ||||
Partial evidence “CellFiber is a Tokyo-based biotechnology company built on proprietary 3D cell-culture technology.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 6 | 15 contacts → | ||||
Strong evidence “We are driving the evolution of next-generation CAR-T cell therapy with precision-engineered CAR constructs.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 7 | 14 contacts → | ||||
Partial evidence “Our aim at Kintaro Cells Power International is a medical supplier of "Kintaro Cells"- Human Bone Marrow Mesenchymal Stromal Cells.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 8 | 13 contacts → | ||||
Strong evidence “Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 9 | 13 contacts → | ||||
Indirect evidence “Chiome Bioscience, Inc.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 10 | 12 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 11 | 11 contacts → | ||||
Partial evidence “Chordia Therapeutics is a clinical-stage biotech company engaged in the research and development of novel therapies for cancers with high unmet medical needs.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 12 | 9 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 13 | 8 contacts → | ||||
Partial evidence “A Kyoto University spinout company having production technologies to generate high performance artificial blood cells from stem cells.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 14 | 7 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 15 | 5 contacts → | ||||
Strong evidence “PeptiGrowth is a supplier of innovative raw materials for the expanding market of regenerative medicine and cell and gene therapy.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 16 | 5 contacts → | ||||
Indirect evidence “A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 17 | 5 contacts → | ||||
Partial evidence “A bio-venture company established with the aim of using ultra-high-purity human bone marrow-derived stem cells "REC®" to help treat various intractable diseases.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 18 | 4 contacts → | ||||
Partial evidence “A biopharmaceutical company developing antibody drugs” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 19 | 4 contacts → | ||||
Strong evidence “Recent development of engineered T cell therapies has demonstrated remarkable efficacy and brought hope to cancer patients.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 20 | 3 contacts → | ||||
Partial evidence “We are specialists of culture media and cells with both manufacturing and contract research functions.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 21 | 3 contacts → | ||||
Indirect evidence “A biotechnology company developing novel medicines with immune regulating technology.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 22 | 3 contacts → | ||||
Strong evidence “We are a clinical stage biopharmaceutical company aspiring to cure solid tumors with our novel TCR like CAR-T cell therapies that enhances the immune system with state of the art…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 23 | 2 contacts → | ||||
Strong evidence “Services we provide in the field of cell & gene therapy -Contracted manufacturing of commercial products (CMO)-Process development and manufacturing of clinical products…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 24 | 2 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 25 | 1 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: biopharmaceutical cell therapy companies. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names biopharmaceutical cell therapy companies.
- Partial evidence
- Its own public description names part of biopharmaceutical cell therapy companies, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name biopharmaceutical cell therapy companies. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 70 biopharmaceutical cell therapy companies based in Japan
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 141 reachable decision-makers.
Free signup · no credit card
Biopharmaceutical cell therapy companies based in Japan at a glance
As of Sep 16, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for Japan, so it is reported there. Company counts and contact totals on this page are exact for Japan, over 70 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among biopharmaceutical cell therapy companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Japan whose own description of what they do matches “biopharmaceutical cell therapy companies”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names biopharmaceutical cell therapy companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among biopharmaceutical cell therapy companies, and records with no verified work email. Companies headquartered outside Japan are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 141 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 16, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names biopharmaceutical cell therapy companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many biopharmaceutical cell therapy companies are there based in Japan?
RevenueBase identified 70 biopharmaceutical cell therapy companies headquartered in Japan as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Reprocell, headquartered in Yokohama, tops this list with the largest team on record.
Which city has the most biopharmaceutical cell therapy companies?
Tokyo leads with 14 headquartered companies, followed by Jing (4) and Kyoto (4).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 141 verified decision-maker contacts tracked across these 70 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 16, 2026.
Ready to reach these companies? Verified emails and direct dials for all 70 biopharmaceutical cell therapy companies based in Japan. Start with a free account, no credit card.
Download this list →Related lists
Biopharmaceutical cell therapy companies by geography
- Biopharmaceutical cell therapy companies based in Boston, United States
- Biopharmaceutical cell therapy companies based in Cambridge, United States
- Biopharmaceutical cell therapy companies based in Houston, United States
- Biopharmaceutical cell therapy companies based in Los Angeles, United States
- Biopharmaceutical cell therapy companies based in New York, United States
- Biopharmaceutical cell therapy companies based in Philadelphia, United States
- Biopharmaceutical cell therapy companies based in San Diego, United States
- Biopharmaceutical cell therapy companies based in San Francisco, United States
- Biopharmaceutical cell therapy companies based in Seattle, United States
- Biopharmaceutical cell therapy companies based in South San Francisco, United States
- Biopharmaceutical cell therapy companies based in Australia
- Biopharmaceutical cell therapy companies based in Canada
Browse the directory
Browse: Companies home · All Japan lists · All Biopharmaceutical cell therapy companies lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Biopharmaceutical cell therapy companies based in Boston, United States
- Biopharmaceutical cell therapy companies based in Cambridge, United States
- Biopharmaceutical cell therapy companies based in Houston, United States
- Biopharmaceutical cell therapy companies based in Los Angeles, United States
- Biopharmaceutical cell therapy companies based in New York, United States
- Biopharmaceutical cell therapy companies based in Philadelphia, United States